SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001765581-20-000125
Filing Date
2020-12-03
Accepted
2020-12-03 18:57:22
Documents
2
Period of Report
2020-12-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 3  
1 PRIMARY DOCUMENT edgardoc.xml 3 1469
2 EDGAR SUPPORTING DOCUMENT poacook2020.txt EX-24 3643
  Complete submission text file 0001765581-20-000125.txt   6652
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Issuer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DENALI THERAPEUTICS INC. 151 OYSTER POINT BLVD., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address
Cook Jennifer E. (Reporting) CIK: 0001754371 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33500 | Film No.: 201368126